Search Articles
Search results
Displaying 1 - 20 of 1396
Cancer,
Science & Research
Combination of breast cancer and chemotherapy may speed up physical decline in older adults
A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.
May 10, 2024
|
4 min read
Cancer,
Science & Research
Adding immune-boosting agent to personalized cancer vaccine supercharges the body's immune defense against malignant brain tumors
Investigators at UCLA Health have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.
May 9, 2024
|
5 min read
Cancer,
Science & Research
Dr. Tanya Stoyanova receives Department of Defense Exploration-Hypothesis Development Award
Dr. Tanya Stoyanova was awarded an Exploration-Hypothesis Development Award from the Department of Defense to develop new approaches to detect and treat neuroendocrine prostate cancer, a highly aggressive subtype of prostate cancer.
May 9, 2024
|
2 min read
Cancer
Helping loved ones through fear, loss after cancer diagnosis
May 8, 2024
|
4 min read
Cancer,
Healthy Lifestyle
Panel urges women to begin screening for breast cancer at younger age
May 8, 2024
|
4 min read
Cancer,
News about UCLA Health
UCLA Health opens new location in Santa Barbara to meet growing needs of the community
UCLA Health has opened a new location in Santa Barbara, housing primary & specialty care and cancer care at one downtown Santa Barbara location in response to the area’s growing demand for the health system’s world-class care.
May 6, 2024
|
2 min read
Cancer,
Science & Research
Dr. John Lee receives grants from Department of Defense
The Department of Defense awarded Dr. John Lee, associate professor-in-residence in the division of Hematology/Oncology at the David Geffen School of Medicine at UCLA, with its Impact and Idea Development Awards to help advance more effective treatments for prostate and bladder cancers.
May 3, 2024
|
2 min read
Cancer,
News about UCLA Health,
Science & Research
New California Institute for Immunology and Immunotherapy to spark research discoveries
May 1, 2024
|
4 min read
Cancer,
Science & Research
New breast cancer screening recommendations aim to address health inequities, especially among Black women
While the recommendations offer a step forward in making screening equitable for populations that have been missed with the previously higher screening starting age, challenges remain in ensuring equitable access to screening.
April 30, 2024
|
3 min read
Cancer
Simms/Mann oncology center is training the next generation of psychosocial care providers
April 24, 2024
|
6 min read
Ask the Doctors,
Cancer
Study looks at role of oral microbe in colorectal cancer
I recently read about a study that found a link between a certain kind of bacteria that lives in your mouth and the risk of developing colon cancer. I would like to know more details about that study, and also if this might point to a new approach in treatments.
April 24, 2024
|
3 min read
Cancer,
Science & Research
UCLA Health urologists will showcase groundbreaking research at the 2024 American Urological Association Annual Meeting
UCLA Health faculty, scientists, and urologists will present research data on the latest discoveries and innovations in urology at the 2024 American Urological Association’s (AUA) Annual Meeting in San Antonio, Texas, May 3-6.
April 24, 2024
|
3 min read
Cancer,
Science & Research
Prostate cancer screenings encouraged for Black men as early as 40
New prostate screening guidelines organized by the Prostate Cancer Foundation aim to address the longstanding health disparity in prostate cancer: Black men are diagnosed with and die from prostate cancer at a much higher rate than white men.
April 24, 2024
|
4 min read
Cancer,
Science & Research
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved outcomes for patients
The FDA approval was based on results of the QUILT 3.032 clinical trial, which was led by Dr. Karim Chamie, associate professor urology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Health Jonsson Comprehensive Cancer Center.
April 23, 2024
|
3 min read
Cancer
Danielle Siegel helps patients process mortality, what's important in life, after a cancer diagnosis
April 19, 2024
|
3 min read
Cancer,
Science & Research
Mutations in noncoding DNA become functional in some cancer-driving genes
UCLA researchers, using an experiment that elucidated the function of tens of thousands of noncoding variants, discovered a link between functional mutations and genes linked to cancer pathways, as well as indicators to predict cancer patient survival.
April 18, 2024
|
5 min read
Cancer,
Science & Research
Cancer researchers receive Team Science Award from Melanoma Research Alliance
The award supports the team’s research in improving a small molecule to break down PD-L1 more effectively and identifying other PD-L1-degrading small chemical compounds.
April 16, 2024
|
2 min read
Cancer,
Science & Research
Advance in immune cell screening uncovers receptors that target prostate cancer
A recent UCLA study demonstrates a new process for screening T cells, part of the body’s natural defenses, for characteristics vital to the success of cell-based treatments.
April 15, 2024
|
4 min read
Cancer
Dr. Beth Karlan named NCCN Guidelines Steering Committee Chair
In this role, Karlan, director of cancer population genetics at the UCLA Health Jonsson Comprehensive Cancer Center, is responsible for overseeing the development, maintenance, and dissemination of clinical practice guidelines for cancer care.
April 12, 2024
|
2 min read
Cancer,
Science & Research
Dr. Matthew Rettig recognized by VA for contributions to prostate cancer research
The award recognizes Rettig’s commitment to improving health care for veterans, as well as his scientific leadership. Along with the honor, Rettig will receive $150,000 over the next three years in research support.
April 11, 2024
|
2 min read